Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study
- PMID: 6722836
Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical